FIELD: pharmacology.
SUBSTANCE: invention relates to a method for the preparation of indole-1-H-, 1-methyl-, 1-benzylindole-3-ylsulfanylacetate of (2-hydroxyethyl)ammonium heterocyclic compounds that have a broad spectrum of action, for example, selective erythropoiesis and immunomodulators with a minimum potential for undesirable effects on various body systems, and can be used to prevent and treat immune-dependent lesions that occur with anaemia, cancer and inflammatory diseases, complications with organs and bone marrow transplantation, protection against cardiogenic shock, stresses, etc. The method consists in the reaction of 1-R-indole-3-ylsulfanyl acetic acids with (2-hydroxyethyl)amines - triethanolamine, methyldiethanolamine, dimethylethanolamine without solvent upon heating to 60-65°C for 0.5-1 hour, with washing of the resulting salt with ether. The yield is 92-99%. The initial 1-R-indole-3-ylsulfanyl acetic acids (compounds 2) are obtained for this reaction from 1-H- or 1-methyl-or 1-benzylindole with thiourea, bromine, potassium bromide, taken in the molar ratios of 1:2:1:1, respectively, in a water medium at a temperature of 30-40°C for 3 h in inert gas, with subsequent processing of the reaction mass by an aqueous solution of sodium hydroxide, then an aqueous solution of monochloroacetic acid taken in the molar ratios of indole, sodium hydroxide, acid 1:(4-5):(1-1.2), heating of the reaction mixture at 90-100°C for 3 h at a pH of 9-10 with subsequent acidification with hydrochloric acid until pH=1 with a yield of 92-95%. Purity is 98.7-99.7. Replacement of scarce and expensive iodine and potassium iodide in alcohol solution with a more accessible aqueous solution of bromine and sodium bromide, excluding toxic hydrazine hydrate and toxic solvent (alcohol) from the process leads to a decrease in product cost and an increase in environmental fire safety, since the reaction is carried out in an aquatic environment. , R=H, CH3, CH2C6H5; R1, R2=H, CH3, CH2CH2OH; n=1-3.
EFFECT: increased efficiency of compounds application.
2 cl, 2 dwg, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ACCELERATED GROWTH OF STAPHYLOCOCCUS AUREUS FOR DIAGNOSTICS OF INFECTIONS ASSOCIATED WITH DELIVERY OF HEALTH CARE | 2012 |
|
RU2511031C1 |
ANTINEOPLASTIC AGENT | 2016 |
|
RU2623034C1 |
METHOD OF PRODUCING 2-METHYL-4-HALOGEN-PHENOXYACETATES OF TRIS-(2-HYDROXYETHYL)AMMONIUM (2-METHYL-4-HALOGEN-PHENOXYACETOXYPROTATRANES) | 2009 |
|
RU2427568C2 |
THE USE OF TRIS-(2-HYDROXYETHYL)AMMONIUM SALT OF 1-BENZYLINDOLYL-3-THIOACETIC ACID AS AN INHIBITOR OF THE ACTIVITY OF HUMAN ENDOGENOUS RETROVIRUS HERV-E λ 4-1 ENV | 2022 |
|
RU2801797C1 |
USING COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE AND ZINC BIS-(2-METHYLPHENOXY-ACETATE) (ZINCATRAN) AS HYPOLIPIDEMIC (ANTIATHEROSCLEROTIC) AGENT | 2014 |
|
RU2575788C1 |
METHOD OF OBTAINING 5-(HET)ARYL-4-(2-THIENYL)-2-(THIO)MORPHOLYLPYRIMIDINE | 2013 |
|
RU2547844C1 |
METHOD OF PRODUCING SULFANYL DERIVATIVES OF ANTIPYRINE | 2020 |
|
RU2740911C1 |
DERIVATIVES OF 3-METHYL-7-(THETANYL-3)-XANTHINE POSSESSING HEMORHEOLOGICAL ACTIVITY | 2006 |
|
RU2316551C1 |
β-CARBOLINE DERIVATIVES, POSSESSING ANTI-TUBERCULOSIS ACTIVITY, THEIR APPLICATION FOR MEDICATION MANUFACTURING, METHOD OF THEIR SYNTHESIS, AS WELL AS NOVEL METHODS OF TREATMENT WITH THEIR APPLICATION | 2010 |
|
RU2419431C1 |
FODDER ADDITIVES REPRESENTED BY DIPEPTIDES | 2010 |
|
RU2536467C2 |
Authors
Dates
2018-01-26—Published
2016-04-04—Filed